Mediplus Targets Middle East Expansion with Arab Health Launch of its New IV Drug Delivery Set

A pioneering IV administration set that allows clinicians to access a variety of pumps and deliver fluids in a safe manner will be launched at Arab Health 2017 by UK manufacturer, Mediplus.

Background

Readers will have picked up the message that Arab Health is around the corner. Appearing for the third time this year is family-run Mediplus, specialist manufacturer of innovative patient centric products for 30 years. The company focuses on two key clinical areas – pelvic floor, which includes urology, urogynaecology, gynaecology, gastroenterology, and critical care which covers anaesthetics and general surgery sectors. Alongside its extensive portfolio, which includes a range of Gold Standard TIVA (Total Intravenous Anaesthesia) solutions, will be Argentum, a new dedicated infusion delivery set, designed to facilitate the administration of intravenous medicines in one complete system. Designed together with clinicians, the innovative system offers convenience to the end user whilst maintaining the highest standards for safe, cost effective drug delivery. It has been developed to facilitate the administration intravenous drugs within general surgery, obstetrics, coronary care, intensive and critical care and recovery. The company currently sells direct to end users in more than forty countries globally and is keen to expand into the Middle East, hence the trip to Arab Health.

Company comments

Emma Gray, Managing Director, said: “The Middle East is of strategic importance to Mediplus as it enables us to offer our leading products to the region and achieve our goals of enabling clinicians to deliver world class, leading care to patients.” “Qatar has recently benefitted from Mediplus’ Gold Standard TIVA solutions and we are keen to continue this growth throughout the Middle Eastern market. We will be at Arab Health to actively seek out companies who have a proven track record in product launches and selling innovative products in the Middle East.”

Source: Mediplus Ltd.

Share your thoughts

Your email address will not be published. Required fields are marked *